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Summary Epidemiological studies of active smokers have shown that the duration of smoking has a much
greater effect on lung cancer risk than the amount smoked. This observation suggests that passive smoking
might be much more harmful than would be predicted from measures of the level of exposure alone, as it is
often of very long duration frequently beginning in early childhood. In this paper we have investigated this
using a multistage model with five stages. The model is shown to provide an excellent fit to data on the
incidence of lung cancer among smokers, ex-smokers and non-smokers in a cohort of male British doctors.
Contrary to our expectation the model predicted only a slight increase in relative risk with increasing duration
of passive exposure. Allowing for exposures early in life does not therefore explain the discrepancy between
the relative risk of about 1.5 calculated from epidemiological studies of lung cancer and the low levels of
exposure indicated by cotinine measurements in those passively exposed.
It has been suggested, using data from epidemiological
studies of lung cancer and passive smoking (i.e. exposure to
other people's tobacco smoke), that the relative risk of lung
cancer among non-smokers living with smokers, compared
to non-smokers living with non-smokers is about 1.5 (see,
for example, Wald et al., 1986). This estimate of relative risk
is considerably higher than one would predict on the basis of
studies of cotinine levels in non-smokers living with smokers
(Committee on Passive Smoking, 1986). It is clear that
epidemiological studies of passive smoking are particularly
difficult to carry out because of the large errors inherent in
obtaining adequate histories of such past exposure and
because the studies need to avoid even slight biases as the
relative risks involved are small.
Epidemiological studies of active smokers have however
shown that the duration of smoking has a much greater
effect on lung cancer risk than the amount smoked. For
example heavy smokers (30 cigarettes per day) of 15 years
duration have been shown to have only about one tenth the
excess lung cancer risk of moderate smokers (15 cigarettes
per day) who have smoked for 30 years, although the total
number of cigarettes smoked is the same (Peto & Doll,
1984). This observation suggests that exposure to tobacco
smoke at the low levels incurred during passive smoking
might be much more harmful than would be predicted from
measures of the level of the exposure alone, as passive
exposure is often of very long duration frequently beginning
in early childhood.
In this paper we have investigated the possible effects of
such long duration exposure to passive smoking starting in
childhood by modelling the effect of cigarette smoke on lung
cancer incidence using a multistage model, and compared the
estimates so obtained to those observed in epidemiological
studies.
A multistage model for lung cancer
The model
The idea that a cancer is generated only after a cell has
undergone a series of distinct, ordered, transformations or
'stages' was introduced to explain the observation that the
mortality rates for many sites of cancer that are epithelial in
origin increase as the fourth, fifth, or sixth power of age.
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Multistage models have also been highly successful in des-
cribing many features of experimental carcinogenesis, for a
review see Peto (1977) or Day (1983). The model as pro-
posed originally by Armitage & Doll (1961) is the best
known formulation and a brief description of it is given in
the Appendix. In this formulation, if there are k stages
involved for the cancer in question (normal cell=stage 'O',
stage 1,.. ., stage k=cancer cell), we denote the probability
that a cell which is at stage i-I transforms into stage i in
unit time as a ai, i=l,...,k. According to this model, if
these ai remain constant throughout life, and if the time for
a fully transformed malignant cell to grow into a clinically
detectable tumour is ignored, then the incidence rate at age t
will be proportional to tk-'. It follows that if the logarithm
of the age-specific incidence rates are plotted against the
logarithm of age, then the plotted points will fall on a
straight line with slope k-1.
Data on the incidence of lung cancer in non-smoking US
males have been published by Kahn (1966) and Hammond
(1966), and together include 127 cases of lung cancer. The
data have been combined by Doll (1971) and are reproduced
in Figure 1. It can be seen that they lie very close to a
straight line with slope four, indicating that five stages are
appropriate in the model for lung cancer. Among regular
cigarette smokers the incidence rises more rapidly with age,
and the slope of the line is about seven, but when the rates
are plotted against duration of smoking, rather than age, the
incidence again rises approximately as the fourth power, see
Figure 1 (Doll, 1971).
In order to understand which stages in the multistage
model are affected by smoking, it is necessary to consider
the following two critical epidemiological observations.
Firstly the fact that age at starting to smoke and duration of
smoking are critical determinants of lung cancer risk, and
secondly the fact that after stopping smoking the incidence
rate remains approximately at the level when smoking
stopped (Doll & Peto, 1976). In terms of the multistage
model, these can be shown to imply that cigarette smoke has
a strong effect on an early stage, probably the first, and also
that it affects a late stage, but not the last (Doll, 1978; Day
& Brown, 1980). When attention is restricted to smokers of
cigarettes only, who also have a record of unchanging
smoking habits, the relation between lung cancer incidence
and number of cigarettes smoked per day is greater than
linear, see Figure 2, and this provides additional evidence
that more than one stage in the process is affected (Doll &
Peto, 1978).
In the present paper we first show that a multistage model
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Figure 2 Comparison of dose-response observed in British
doctors' study with that obtained from the proposed multi-stage
model. 0 - Relative risks indirectly standardized for age from
Doll & Peto (1978), Table IV. (Printed values have been divided
by 0.081 so that 0 cigarettes per day takes value 1.) Solid line-
Relative risks predicted from the model. Values plotted are
weighted sums of age-specific relative risks with weights equal to
those used by Doll & Peto (1978), Table IV, for indirect
standardization.
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Figure 1 Incidence of bronchial carcinoma in non-smokers by
age (A) and in regular cigarette smokers by age (0) and
duration of smoking (0). Solid lines have slope 4. Data for non-
smokers from Doll (1971, Table VI). Data for smokers from
Doll & Peto (1978) Table II, directly standardized for amount
smoked.
with five stages in which cigarette smoke affects the first and
the fourth stage provides a highly satisfactory description of
the patterns of lung cancer observed among active cigarette
smokers. The patterns of lung cancer risk predicted by the
model when the quantity of cigarettes smoked per day is
very low, such as might effectively be smoked under con-
ditions of passive exposure, are then explored.
Active smokers
Data on the numbers of lung cancers diagnosed and the
distribution of man-years from a 20-year prospective study
of male British doctors have been published by Doll & Peto
(1978) for people who either reported that they were lifelong
non-smokers, or who reported that they had smoked cigar-
ettes regularly since early adult life, without either giving up
or changing their consumption by more than five cigarettes
per day, and who also reported no current or previous use of
cigars or pipe. The data are available in the form of numbers
of diagnosed lung cancers and man-years at risk in Tables II
and III of Doll & Peto (1978) by current age in five-year
groups, and numbers of cigarettes smoked per day (Never
smoked, 1-4, 5-9, 10-14, etc.).
The lung cancer risk at age t, as predicted by our
multistage model, for an individual who started smoking at
age s and from then on smoked c cigarettes per day, relative
to a lifelong non-smoker, is given in the Appendix. It
depends on two parameters, b1 and b4, which are respec-
tively the proportional amounts by which the rate of trans-
formations to the first and the fourth stages of the
carcinogenic process are increased by each cigarette smoked
per day; specifically al becomes a,(1 +cbl) and a4 becomes
a4(1+cb4) during the time in which c cigarettes per day are
smoked. The values of the parameters b1 and b4 were
estimated by the method of maximum likelihood, conditional
on the total number of incident lung cancers in each age
group, and using data from the British doctors' study for
individuals who were aged from 40 to 79 years, and who
smoked up to 40 cigarettes per day. We have ignored data
on doctors who reported smoking more than 40 cigarettes/
day, as did Doll and Peto in their analysis; a full discussion
of the reasons for omitting them is given in Doll & Peto
(1978). In the data all the doctors had started smoking when
they were between 16 and 25 years old. In estimating b, and
b4 it was assumed for simplicity that all the smokers had
started smoking at 20 years of age. This method of fitting
enables the effect of cigarette smoking to be estimated in
terms of relative risks. To make predictions in terms of
absolute incidence rates we have assumed in what follows
that the incidence rate in non-smokers at age 60 is equal to
that observed in the data on non-smokers in Figure 1.
The estimated values for b, and b4 are 0.29 and 0.37 with
estimated standard errors of 0.32 and 0.35. The fit of the
model to the British doctors' data is excellent. Pearson's
goodness-of-fit statistic is 52.4 and the residual deviance is
51.1; both of these statistics have 54 degrees of freedom and
thus provide no evidence of a poor fit to the data. A plot of
standardized residuals against normal order statistics indi-
cated that the model fitted the data well, and plots of
residuals against both current age and number of cigarettes
smoked per day gave no evidence of systematic departures
from the model.
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The ability of the model to reproduce the main features of
cigarette smoking, as observed in the British doctors' study,
is illustrated in Figures 2 to 4. In Figure 2 it can be seen that
the dose response relationship from the multistage model
reproduces very closely the approximately quadratic relation-
ship observed in the data. Figure 3 shows the annual
incidence of lung cancer in smokers and non-smokers as
predicted by the model. The predictions have been made
assuming that all smokers started smoking on reaching age
20, and smoked 20 cigarettes per day. These values are
similar to the average values of 19.2 years and 18 cigarettes
per day observed in the British doctors' data. By comparing
Figures 1 and 3 it can be seen that, once again, the proposed
model reproduces very closely the patterns of increase in
lung cancer incidence seen in the original data.
Figure 4a shows data on the risk of lung cancer among
British doctors who stopped smoking, by time since stop-
ping, relative to their risk at the time they stopped. For
comparison, risks are shown on the same scale for con-
tinuing cigarette smokers and lifelong non-smokers. The
beneficial effect of stopping smoking is evident within five
years, and there is a possibility that the incidence rate may
actually decrease during the first 10 years after stopping
smoking. However, the data are too few to be certain that
this is so, and it is clear that the risk keeps well above that
for lifelong non-smokers (Doll, 1978). The equation predict-
ing the effect of giving up smoking according to the
multistage model is given in the Appendix, and it is illus-
trated in Figure 4b, where it is assumed that the smokers
1000 -
ooo -
Cl a)
E 100-
0
0
0
0
0
a)
a)
c
.)
c 'a 0)
c
0
c)
0)
:3 10 -
C
C
0
a
10.0 -
5.0 -
I'd
. 1.0i
a)
,._-
Co 0.5-
cc
0.1-
0.05-
0
_ IT_ L IT 0
I
.LI
-I
i
0
0
0
I
0 5 10 15 20 25
Years stopped
b
10.0-
5.0
0
0
.
- 0 0C 1.0-
a)
-m 0.5-
cc
01-
0.05 -
0
0
0
0
0
A
0 ~~~~A
A
A A
0
0
0
0
0
0 5 10 15
Years stopped
A Ex-cigarette smoker
* Cigarette smokers of the same age
o Non-smokers of same age
I -
20 30 40 50 607080
Years
Figure 3 Incidence of bronchial carcinoma as predicted by the
model in non-smokers by age (A) and in smokers of 20
cigarettes per day from age 20 by age (0) and duration of
smoking (0). Solid lines have slope 4.
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Figure 4 Comparison of the effect of stopping smoking
observed in British doctors' study with that obtained from the
proposed multistage model. Risk is measured relative to the risk
in a regular cigarette smoker at the ages at which smoking was
stopped (a) Data from British doctors' study, amd US non-
smokers standardized for amount smoked at time of stopping.
(Data from Doll. 1978, chart 6, reproduced with permission.) (b)
Predictions from the model, assuming smokers consumed 20
cigarettes per day from age 20 to age 50, and then stopped.
consumed 20 cigarettes per day from age 20 to age 50 and
then stopped. As was seen in the doctors' study, the
beneficial effect of stopping is seen after only a few years,
and the risk among those who stopped is clearly inter-
mediate between those seen in continuing smokers and in
lifelong non-smokers. From the model predictions there is no
suggestion that the relative risk falls below one in the first
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few years after stopping, and using the equation for the
relative risk in an ex-smoker shown in the Appendix it can
be shown that under the proposed model the incidence of
lung cancer will never decrease below that already reached at
the time of stopping smoking regardless of amount smoked
or ages at starting and stopping. There is evidence from
pathological studies of tracheo-bronchial trees that the
number of atypical nuclei in the bronchial epithelium dimi-
nishes on cessation of smoking (Auerbach et al., 1962), and
this observation lends some support to the idea that the risk
of lung cancer might actually decrease in the first few years
after giving up smoking. However, the slight discrepancy
between the observations on British doctors and the predic-
tions from the model could also be accounted for by random
variation, or by the fact that individuals who succeed in
giving up smoking were less likely to inhale than continuing
smokers (Doll & Hill, 1964).
Overall the ability of this multistage model to reproduce
the main features of cigarette smoking, as observed in the
British doctors' study seems remarkable.
Passive smoking
The predictions of the model when the number of cigarettes
smoked per day is low, including the range of exposures
indicated by the risks observed in epidemiological studies of
passive smoking, are shown in Table I. The predictions have
been made for an individual aged 65 assuming first that the
individual was exposed continuously from birth, secondly
that the individual was unexposed until age 20 but exposed
continuously since then, as might happen for a non-smoking
individual who married a smoker or started work in a smoky
environment at age 20, and thirdly that the individual was
exposed only between birth and age 20, as might occur in
individuals whose parents smoked, but who were not other-
wise exposed. A number of points emerge. First, on a
relative scale at least, the risks are substantial. The predicted
effect of smoking the equivalent of only one cigarette per
day from birth to age 65 is to increase lung cancer risk by
more than 75%, while if exposure starts at age 20 the risk is
increased by 46% and if exposure is limited to childhood the
risk is increased by 23%. Secondly, for exposures up to the
equivalent of three cigarettes per day, exposure in childhood
only is predicted to incur about half the increase in risk of
exposure at the same level in adult life only. Thirdly, and
most strikingly, although the risk is greater if exposure
occurs both in childhood and in adult life than if it occurs in
only one of the two periods, the drastic increase in risk with
increasing duration of exposure, seen in active smokers, is
absent. For example, exposure at the rate of one cigarette
per day from birth to age 65 incurs only a 21% greater
relative risk than exposure at the rate of one cigarette per
day from age 20 to age 65 (1.77 compared with 1.46). Direct
analogy with the effect of duration of smoking as seen in
active smokers of around 20 cigarettes per day would have
predicted nearly a four-fold increase.
The importance of duration of exposure in determining
the increase in relative risk diminishes with diminishing level
of exposure. This is illustrated in Table II where the lung
cancer relative risks predicted by the model are shown for a
wide range of levels of exposure. For smokers of 20 cigar-
ettes per day, relative risks by age 60 are more than 50%
greater than they were at age 40, but at low levels, such as
half a cigarette per day, the proportionate increase in relative
risk is less than 3% over the same period.
The above calculations have all been made assuming that
the British doctors were not themselves exposed to passive
smoke. As regards exposure in childhood this assumption is
Table I Effect of passive smoking on lung cancer risk at age 65, as predicted by the
model
Risk relative to a non-exposed non-smoker
Effective passive
smoking (cigarettes
per day equivalent)
0.00
0.10
0.20
0.25
0.50
1.00
1.50
2.00
3.00
4.00
5.00
Exposure from
age 0 to
age 65
1.00
1.07
1.14
1.17
1.36
1.77
2.23
2.75
3.95
5.36
6.98
Exposure from
age 20 to
age 65 only
1.00
1.04
1.09
1.11
1.22
1.46
1.71
1.97
2.52
3.13
3.78
Exposure from
age 0 to
age 20 only
1.00
1.02
1.05
1.06
1.11
1.23
1.34
1.46
1.69
1.93
2.16
Table II Lung cancer risk predicted from the model for smoking a constant
number ofcigarettes per day starting at age 20. Figures shown are risks relative to
that for a non-exposed non-smoker by current age and number of cigarettes per
day
Cigarettes per day
Current
age 0.1 0.5 1.0 5.0 10.0 20.0 30.0
40 1.036 1.184 1.37 2.99 5.31 10.96 17.94
50 1.040 1.202 1.41 3.33 6.36 14.50 25.42
60 1.042 1.216 1.44 3.64 7.33 17.90 32.71
70 1.044 1.228 1.47 3.91 8.21 21.01 39.39
80 1.046 1.238 1.49 4.14 8.99 23.76 45.32
Above relative risks divided by relative risk at age 40:
40 1.000 1.000 1.00 1.00 1.00 1.00 1.00
50 1.003 1.016 1.03 1.12 1.20 1.32 1.42
60 1.006 1.027 1.05 1.22 1.38 1.63 1.82
70 1.008 1.037 1.07 1.31 1.55 1.92 2.19
80 1.009 1.046 1.09 1.39 1.69 2.17 2.52PASSIVE SMOKING AND LUNG CANCER 829
probably reasonable, as all individuals would have dates of
birth before about 1926. In the 1920s cigarette consumption
among women (including the mothers of the British doctors)
was very low, while that among men was less than in
subsequent years (Lee, 1976). In contrast, passive exposure
in adult life may well have been substantial in the doctors'
cohort by present day standards, as the vast majority of
men, doctors included (Doll & Peto, 1976), smoked cigar-
ettes in 1951 when the cohort was identified, and when there
was little public awareness of the risks of either active or
passive smoking. In order to illustrate the possible effect of
passive smoking among the British doctors on the predic-
tions shown in Table I, estimates of the parameters in the
multistage model were recalculated assuming, as an example,
that all the doctors, both smokers and non-smokers, were
exposed to passive cigarette smoking at a rate equivalent to
one cigarette per day throughout their adult life. The revised
model predictions from this example are shown in Table III.
The general effect of making the allowance for passive
smoking is a small increase in the predicted relative risks
which is of the order of 10 to 20% for passive smoking
exposures of half to one cigarette per day equivalent. For
exposures of five cigarettes per day, larger increases in
relative risk are implied, and for an individual who has been
exposed at a rate of five cigarettes per day from age 20 the
predicted risk at age 65 relative to a lifelong non-smoker is
increased by nearly 40% from 3.78 to 5.24. However the
general conclusions based on the predictions in Table I
remain unchanged. In practice non-smokers are, of course,
likely to have much less passive smoking exposure than
smokers; when this is taken into account the changes shown
in Table III are, of course, reduced and the true effects are
thus likely to be bounded by the results in Table I and Table
III.
Discussion
Multistage models for the development of cancer are pos-
sibly no more than a crude mathematical description of a
complex biological process. Nevertheless the proposed multi-
stage model has been shown to provide an accurate coherent
summary of the patterns of lung cancer risk among active
smokers, ex-smokers, and non-smokers. It is likely therefore
also to provide good estimates of the pattern of lung cancer
risk following exposure equivalent to smoking between 0.1
and five cigarettes per day. It should also provide a reason-
able guide to the consequences of environmental exposure to
other people's smoke (passive smoking). It should in particu-
lar provide guidance on topics on which accurate human
data is likely to remain sparse, such as the likely effects of
variation in the age at which passive exposure began and of
variation in the duration of such exposure, although of
course in the absence of validatory data it cannot be
concluded with certainty that the model predictions in this
low dose range are correct.
Among active smokers, age at starting to smoke and
duration of the smoking habit strongly determine the risk of
lung cancer, and these features are accommodated in our
model by the assumption that exposure to cigarette smoke
affects the first stage. We therefore anticipated that the
model would predict a substantial increase in relative risk for
exposures starting in early childhood. However, our expec-
tations were not supported by the model predictions, which
indicate an increase in the relative risk of no more than
about 20% for exposure starting at birth compared to
exposure starting at age 20, for exposures equivalent to the
range one tenth to one cigarette per day. If the 'adult
exposure' had been assumed to start at an earlier age than
20, reflecting the fact that in recent surveys in Britain the
median recalled age at starting to smoke is 16-17 (Wald et
al., 1988), the increase in relative risk for lifelong exposure,
as compared with exposure in adult life only, would have
been even smaller.
The relative risks associated with exposures in the range
one tenth to one cigarette per day are less than two, and are
thus smaller than the underlying background risk of lung
cancer due to causes other than cigarettes. Exposure to at
least some of these is likely to commence at birth or in early
childhood. On this basis it is more helpful to think of the
early commencement of passive smoking at rates equivalent
to one cigarette per day or less as an increase in the dose of
an existing carcinogenic exposure rather than an increase in
the duration of passive smoking exposure.
In terms of the mathematical formulation of the model
given in the Appendix, it is clear from the expression for
IC(s, t), the incidence rate at age t in the smoker of c
cigarettes per day since age s, that as c increases the term
involving c2b1b4, which involves duration to the fourth
power, will begin to dominate. For small values of c (i.e. less
than bj 1 and b4 1) it can easily be shown that the term
involving cb4, which increases only very slowly with
duration, will play the major role in determining the inci-
dence rate for values of b1, b4, s and t that are of concern
here. In non-mathematical terms this amounts to the fact
that, for active smokers of a substantial number of cigar-
ettes, the incidence rate of lung cancer is determined by the
effect of smoking on both the first and the fourth stages. In
contrast, at levels equal to the numbers of cigarettes effec-
tively smoked by passive smokers, the effect of those cigar-
ettes is primarily on the fourth stage, and its effect on the
first stage is relatively minor.
Wald et al. (1986) have reviewed the 13 epidemiological
studies of lung cancer and passive smoking which have been
carried out in six different countries. When the results are
combined, these studies suggest that the relative risk of lung
Table III Effect of passive smoking on lung cancer risk at age 65, as predicted by
the model, allowing for passive smoking at a rate equivalent to smoking one cigarette
per day from age 20 in the British doctors
Risk relative to a non-exposed non-smoker
Effective passive Exposure from Exposure from Exposure from
smoking (cigarettes age 0 to age 20 to age 0 to
per day equivalent) age 65 age 65 only age 20 only
0.00 1.00 1.00 1.00
0.10 1.09 1.06 1.03
0.20 1.19 1.13 1.05
0.25 1.23 1.16 1.06
0.50 1.49 1.33 1.13
1.00 2.07 1.68 1.25
1.50 2.75 2.05 1.38
2.00 3.51 2.44 1.51
3.00 5.31 3.29 1.76
4.00 7.48 4.22 2.03
5.00 10.01 5.24 2.29830 S.C. DARBY & M.C. PIKE
cancer among non-smokers living with smokers compared to
non-smokers living with non-smokers is about 1.35. Wald et
al. estimated that adjustment for the likely extent of mis-
classification of some current smokers and some ex-smokers
as non-smokers (never-smokers) reduces this estimate to
1.30, but estimated that allowance for the fact that people
living with non-smokers may still be exposed to other
people's smoke increases the estimate to 1.53. (This latter
adjustment is similar in magnitude to the effect of allowing
for exposure to environmental tobacco smoke among the
British doctors in estimating the parameters of our multi-
stage model, see Table III.)
Although the US National Academy of Science's Com-
mittee on Passive Smoking (1986) accepted the estimates of
Wald et al., other authors have disputed them and claimed
that the increased lung cancer risk seen among non-smokers
exposed to passive smoking is largely the effect of bias due
to the misclassification problems we mentioned above. For
example, Lee (1987) suggested, on the basis of recent surveys
carried out in the UK for the Tobacco Advisory Council,
that the proportion of true ex-smokers amongst persons
claiming to be lifelong non-smokers was double the estimate
used by Wald et al. Lee also suggested that the average
number of cigarettes per day smoked by current smokers
claiming to be non-smokers was considerably more than
estimated by Wald et al. and was at least half that of people
admitting to being smokers. These assumptions lead to a
much lower estimate for the lung cancer risk from passive
smoking, and Lee concluded that almost no lung cancer is
caused by passive smoking. In our opinion, Lee's estimate of
the average number of cigarettes smoked per day (an
important determinant in the risk estimation) among current
smokers claiming to be non-smokers seems excessive, but it
is hard to judge on the basis of published data how either
the estimates of Wald et al. or Lee relate to the individual
studies that led to the combined estimate of 1.35. Further
work is required on the extent of misclassification in the
actual populations in which the epidemiological studies were
done.
The biological marker that has proved most useful in
assessing average daily exposure to tobacco smoke among
those exposed to passive smoking is cotinine (Committee on
Passive Smoking, 1986). Recent studies in the UK measuring
cotinine levels in active and passive smokers in plasma, urine
and saliva indicate that levels in passive smokers are in the
range 0.6 to 0.8% of those in active smokers (Jarvis et al.,
1984). However the half-life of cotinine in non-smokers may
be roughly 50% longer than in active smokers (Sepkovic et
al., 1986). Active smokers in the UK currently smoke
between 15 and 20 cigarettes per day (Wald et al., 1988) and
so the cotinine measurements indicate an exposure of
between 0.06 and 0.11 cigarettes per day. According to the
proposed multistage model, a relative risk of 1.5, as esti-
mated by Wald et al. (1986) from the epidemiological studies
of exposure to passive smoking, results from the effective
exposure to about half to one cigarette per day. Thus the
cotinine measurements indicate a level of exposure that is
between one seventeenth and one fifth the amount indicated
by our model. This estimate is based on cigarettes available
during the 1950s and 1960s and used by the men in the
British doctors' study: to the extent that currently available
cigarettes are associated with lower lung cancer risks these
factors would be somewhat reduced. A further difficulty is
that the relationship between the amount of nicotine
absorbed, and the amount of tar deposited on the bronchi is
not necessarily the same in passive as in active smoking, and
this could influence the postulated risk in either direction.
We conclude, however, that the relative risks of lung cancer
due to passive smoking as estimated by Wald et al. (1986)
seem to be at variance with the numbers of cigarettes per
day equivalent estimated from cotinine measurements. This
discrepancy remains even when allowance is made, within
the framework of our model, for the fact that passive
smoking may commence in early childhood, and when the
parameters of the model are estimated allowing the British
doctors' themselves to have been exposed to passive
smoking.
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Appendix
It is assumed that there are five ordered stages in the carcinogenic
process, that the rate of transition of a cell from stage to stage is
constant in time apart from specified increases in the exposure
intensity, that tumour growth time is negligible and that tumours are
rare.
Let P4(t) be the probability that a specific cell has undergone four
changes at time t. When exposure is to background exposure
intensities only, let P4(t) be denoted by P4(t), and let the transition
rates from stage to stage be ai, i= 1, . . . 5. It follows that
t X4 X3 X2
P4(t) =k Ia4 J a3 | a2 l a,dx,dX2dX3dX4
0 0 0 0
=kja4a3a2ajt4/4!
where k, is a constant. If I°(t) is the associated incidence rate of lung
cancer for a background only exposed individual at age t, then
I°(t)=k2a5P4(t)
=k3a5a4a3a2a,t4/4!,
where k2 and k3 are constants that include an allowance for the
number of cells in the individual at risk of developing lung cancer.
For an individual who begins to smoke cigarettes at age s at the
rate of c cigarettes per day and continues to smoke until age t, let
the transition rate from stage zero to stage one be altered from a, to
al(l +cbj) after age s, and similarly let that for stage three to stage
four be altered from a4 to a4(1+cb4). In such a smoker, let the
probability that in any individual cell the first (i-1) transitions
occur before age s, and the remaining (5-i) after that age be
denoted by P(')(s,t) for i=l.... 4. Then
t X4 xi
P¶"(s,t) =k,Ia*I a* ...Iar*dxi ... dx4
s s s
s X,-, X2
xJai-l I ai 2... I a,dxl...dxi-l
0 0 0
where a4*=a4(1 +cb4),a*=a3, a*=a2, and al=aj(1 +cbj), and the
probability, P?(s,t), that the smoker has a specific cell that has
undergone 4 changes at time t is given by
P4(s,t)= EP)(t).
i=l
It follows straightforwardly from substitution that the lung cancer
incidence rate at age t in the smoker of c cigarettes per day since age
s, Ic(s,t), is given by
Ic(s,t)=k3a5a4a3a2a1t4/4! x [1+cb,(t-s)4/t4
+cb4(1-s4/t4) +c2blb4(t-s)4/t4]
and the age-specific relative risk for such an individual compared to
a lifelong non-smoker of the same age, Rc(s,t), is given by
Rc(s,t) = 1 +cbl(t-s)4/t4+cb4(l _s4/t4)+c2blb4(t-s)4/t4.
By using a similar argument it can be shown that for an individual
of age t who began to smoke cigarettes at the rate of c per day until
stopping at age u, the age specific risk compared to a lifelong non-
smoker, RC(s,u,t) is given by
RC(s,u,t) = 1 +cb1{(t -s)4-(t-u)4}/t4+cb4(u4 -s4)/t4
+C blb4(u-s)4/t4.